FDX vs MRKR · P/E 18, rev $94.72B vs rev $751.7K
FedEx Corporation (FDX) versus Marker Therapeutics Inc (MRKR) — a side-by-side from cached financials, not a winner call.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
FDX currently screens at market cap $78.98B and trailing P/E 17.7. MRKR currently screens at market cap $25.3M.
Not investment advice. Open the FDX and MRKR stock pages for the full models.
Not investment advice.